8月25日晚,Mirxes Holding Company Limited(股份代号:2629.HK)(后简称Mirxes觅瑞)正式发布了截至2025年6月30日的中期业绩。作为一家专注于 miRNA 技术的生物科技公司,公告展现出公司在核心产品商业化进程、财务指标优化以及研发管线推进等关键层面,均取得了显著成果,彰显出强大的增长潜能。 收益稳健上扬,财务结构持续优化 由已公布的数据可知,...
Source Link8月25日晚,Mirxes Holding Company Limited(股份代号:2629.HK)(后简称Mirxes觅瑞)正式发布了截至2025年6月30日的中期业绩。作为一家专注于 miRNA 技术的生物科技公司,公告展现出公司在核心产品商业化进程、财务指标优化以及研发管线推进等关键层面,均取得了显著成果,彰显出强大的增长潜能。 收益稳健上扬,财务结构持续优化 由已公布的数据可知,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.